Research Insights
Deep-dive research insights on NMN clinical trials, regulatory landscape, methylation chemistry, and the major lab updates shaping the field in 2026.
-
NMN Clinical Trials 2026 Roundup: What the Last Six Years of Human Evidence Actually Shows
A 2026 audit of every published human NMN trial - Yoshino, Igarashi, Kim, Liao, Pencina - with effect sizes, sample sizes, and what holds up.
-
NMN + TMG Stack Evidence: What's Real, What's Theoretical, and Why Sinclair Recommends It
A research-led look at the methylation chemistry behind NMN+TMG stacking, the homocysteine evidence, and what the published trial data actually supports.
-
NPRA Malaysia's Stance on NMN: Registration Status, Regulatory Framework, and What It Means for Buyers
How Malaysia's National Pharmaceutical Regulatory Agency (NPRA) treats NMN as a supplement, what registration means, and how to verify product status.
-
David Sinclair Lab Updates 2026: What's New, What Held Up, What Didn't
A 2026 review of David Sinclair's NMN research, public communications, and how Lifespan-era expectations compare with human trial evidence.